Scotts Miracle-Gro (SMG) director sells 831 shares at $61.65 in August trade

Rhea-AI Filing Summary

Scotts Miracle-Gro Co director Mark D. Kingdon reported a sale of 831 Common Shares on 2026-08-10 in a non-derivative transaction. The shares were sold at a price of $61.645 per share, leaving him with 10,827 Common Shares held by direct ownership.

Insider Trade Summary

Net Seller: 831 shares

Net Sell 1 txn

Insider Kingdon Mark D

Role Director

Sold 831 shs ($51K)

Type	Security	Shares	Price	Value
Sale	Common Shares	831	$61.645	$51K

Holdings After Transaction: Common Shares — 10,827 shares (Direct)

Key Figures

Shares sold: 831 Common Shares Sale price: $61.645 per share Shares owned after transaction: 10,827 Common Shares +1 more

4 metrics

Shares sold 831 Common Shares Non-derivative sale by director on 2026-08-10

Sale price $61.645 per share Price for 831 Common Shares sold on 2026-08-10

Shares owned after transaction 10,827 Common Shares Direct ownership position after reported sale

Net shares sold in filing 831 shares transactionSummary net-sell shares

Key Terms

non-derivative, direct ownership, Rule 10b5-1

3 terms

non-derivative financial

"The sale was reported as a non-derivative transaction in Common Shares."

direct ownership financial

"The 10,827 Common Shares remaining are reported as held by direct ownership."

Rule 10b5-1 financial

"The Rule 10b5-1 checkbox is not checked for this transaction."

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/11/2026 - 09:27 AM Accepted by SEC EDGAR 08/11/2026 - 09:26 AM Learn about SEC filing dates

FAQ

What insider transaction did Scotts Miracle-Gro (SMG) disclose for Mark D. Kingdon?

Scotts Miracle-Gro disclosed that director Mark D. Kingdon sold 831 Common Shares on 2026-08-10. The transaction was reported as a non-derivative sale of the company’s common stock.

How many Scotts Miracle-Gro (SMG) shares did the director sell and at what price?

Mark D. Kingdon sold 831 Common Shares of Scotts Miracle-Gro at a price of $61.645 per share. This sale was categorized as a sale in open market or private transaction.

How many Scotts Miracle-Gro (SMG) shares does Mark D. Kingdon hold after the reported sale?

After the sale, Mark D. Kingdon holds 10,827 Common Shares of Scotts Miracle-Gro. These shares are reported as held by direct ownership following the 831-share disposition.

Was the Scotts Miracle-Gro (SMG) insider sale under a Rule 10b5-1 trading plan?

The filing’s Rule 10b5-1 checkbox is not checked, so the sale is not affirmed as executed under a Rule 10b5-1 trading plan. No alternative trading arrangement is described in the data provided.

What is the net effect of the reported Scotts Miracle-Gro (SMG) insider trade on share ownership?

The net effect is a disposition of 831 shares, leaving the reporting director with 10,827 Common Shares. The transactionSummary characterizes this as a net-sell of 831 shares for this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kingdon Mark D

(Last) (First) (Middle)

C/O THE SCOTTS MIRACLE-GRO COMPANY

14111 SCOTTSLAWN ROAD

(Street)

MARYSVILLE OHIO 43041

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
SCOTTS MIRACLE-GRO CO [ SMG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	08/10/2026		S		831	D	$61.645	10,827	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Kathy L. Uttley as attorney-in-fact for Mark D. Kingdon	08/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)